Absci (ABSI) Current Assets (2020 - 2026)
Absci (ABSI) posted Current Assets of $132.0 million for Q1 2026, down 11.77% sequentially from $149.6 million in Q4 2025, and down 15.39% YoY from $156.0 million in Q1 2025.
Absci (ABSI) Current Assets (2020 - 2026) Analysis & Trends
Absci has reported Current Assets for 7 years, with the latest figure at $132.0 million in Q1 2026.
- Quarterly Current Assets fell 15.39% year-over-year to $132.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $132.0 million (down 15.39% YoY) and the FY2025 annual result came in at $149.6 million, up 11.76% from the prior year.
- Current Assets eased to $132.0 million in Q1 2026 per ABSI's latest filing, from $149.6 million in the prior quarter.
- Over five years, Current Assets peaked at $256.0 million in Q1 2022 and troughed at $120.6 million in Q4 2023.
- A 5-year average of $166.0 million and a median of $156.0 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets jumped 102.76% in 2022, then plunged 35.47% in 2023.
- Over 5 years, Current Assets stood at $186.9 million in 2022, then slumped by 35.47% to $120.6 million in 2023, then advanced by 10.99% to $133.8 million in 2024, then rose by 11.76% to $149.6 million in 2025, then dropped by 11.77% to $132.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $132.0 million, $149.6 million, and $175.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 208.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 208.27 Mn |
| Mar 31, 2026 | 131.97 Mn |
| Dec 31, 2025 | 149.57 Mn |
| Sep 30, 2025 | 174.99 Mn |
| Jun 30, 2025 | 137.40 Mn |
| Mar 31, 2025 | 155.98 Mn |
| Dec 31, 2024 | 133.83 Mn |
| Sep 30, 2024 | 150.14 Mn |
| Jun 30, 2024 | 165.19 Mn |
| Mar 31, 2024 | 181.80 Mn |
| Dec 31, 2023 | 120.58 Mn |
| Sep 30, 2023 | 134.71 Mn |
| Jun 30, 2023 | 148.04 Mn |
| Mar 31, 2023 | 165.32 Mn |
| Dec 31, 2022 | 186.86 Mn |
| Sep 30, 2022 | 201.38 Mn |
| Jun 30, 2022 | 227.89 Mn |
| Mar 31, 2022 | 255.96 Mn |
| Dec 31, 2021 | 273.08 Mn |
| Sep 30, 2021 | 300.67 Mn |